Zimmerman Jacqueline, Fisher Martin
Division of Adolescent Medicine, Northwell Health, Hofstra Northwell School of Medicine, Cohen Children׳s Medical Center, Hempstead, NY.
Curr Probl Pediatr Adolesc Health Care. 2017 Apr;47(4):95-103. doi: 10.1016/j.cppeds.2017.02.005.
Avoidant/restrictive food intake disorder (ARFID) is an entirely new diagnosis in the DSM-5. ARFID replaces "feeding disorder of infancy or early childhood," which was a diagnosis in the DSM-IV restricted to children 6 years of age or younger; ARFID has no such age limitations and it is distinct from anorexia nervosa and bulimia nervosa in that there is no body image disturbance. ARFID involves a complex and heterogenous etiology, which is reviewed herein. What is known to date regarding the characteristics and medical and psychiatric comorbidities of this patient population are described and compared to other eating disorders. Evaluation and management strategies are also discussed. No data yet exist regarding ARFID׳s prognosis and prevention; however, recommendations to guide parents in establishing appropriate infant and child feeding practices are provided.
回避性/限制性食物摄入障碍(ARFID)是《精神疾病诊断与统计手册》第五版(DSM-5)中全新的诊断类别。ARFID取代了“婴幼儿喂养障碍”,后者是《精神疾病诊断与统计手册》第四版(DSM-IV)中的诊断,仅限于6岁及以下儿童;ARFID没有此类年龄限制,且与神经性厌食症和神经性贪食症不同,不存在身体意象障碍。ARFID涉及复杂且异质性的病因,本文将对此进行综述。本文描述了该患者群体目前已知的特征、医学和精神共病情况,并与其他饮食失调症进行了比较。还讨论了评估和管理策略。目前尚无关于ARFID预后和预防的数据;不过,本文提供了指导家长建立适当婴幼儿喂养习惯的建议。